SCHEMBL9531246

SCHEMBL9531246

CC1(C)Nc2ccc(Cl)cc2[C@@H](N2CCCC2=O)[C@@H]1O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCC9 O60706 2/20 0.43
▸ ABCC8 Q09428 2/20 0.43
▸ KCNJ11 Q14654 2/20 0.43
▸ KCNJ8 Q15842 2/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ ATM Q13315 1/20 0.36
▸ LRRK2 Q5S007 1/20 0.34
▸ PDE7A Q13946 1/20 0.34
▸ MAPT P10636 2/20 0.33
▸ HTR2C P28335 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9530832 1.00 ABCC9 (0.43) ABCC9ABCC8KCNJ11KCNJ8CYP1A2
SCHEMBL9530830 1.00 ABCC9 (0.43) ABCC9ABCC8KCNJ11KCNJ8CYP1A2
SCHEMBL9531495 0.86 LMNA (0.43) ABCC9ABCC8KCNJ11KCNJ8CYP1A2
SCHEMBL10543412 0.86 LMNA (0.43) ABCC9ABCC8KCNJ11KCNJ8CYP1A2
SCHEMBL10538984 0.86 LMNA (0.43) ABCC9ABCC8KCNJ11KCNJ8CYP1A2
SCHEMBL9531501 0.86 LMNA (0.43) ABCC9ABCC8KCNJ11KCNJ8CYP1A2
SCHEMBL9529808 0.86 LMNA (0.43) ABCC9ABCC8KCNJ11KCNJ8CYP1A2
SCHEMBL9530450 0.83 ABCC9 (0.64) ABCC9ABCC8KCNJ11KCNJ8CYP1A2
SCHEMBL9530480 0.83 ABCC9 (0.64) ABCC9ABCC8KCNJ11KCNJ8CYP1A2
SCHEMBL9530475 0.83 ABCC9 (0.64) ABCC9ABCC8KCNJ11KCNJ8CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0214743-B1 USE OF QUINOLINE DERIVATIVES IN THE MANUFACTURE OF MEDICAMENTS FOR THE TREATMENT OF CEREBROVASCULAR DISORDERS AND CEREBRAL SENILITY BEECHAM GROUP PLC (GB) 1993-05-12 — — EP claimed
EP-0150202-B1 DI/TETRA-HYDROQUINOLINES BEECHAM GROUP PLC (GB) 1988-07-06 — — EP claimed
EP-0214743-A2 Use of quinoline derivatives in the manufacture of medicaments for the treatment of cerebrovascular disorders and cerebral senility BEECHAM GROUP PLC (GB) 1987-03-18 — — EP claimed
US-4808619-A HYPOTENSIVE AGENT, COGNITION ACTIVATOR BEECHAM GROUP P.L.C. (GB) 1989-02-28 — — US disclosed
EP-0150202-B1 DI/TETRA-HYDROQUINOLINES BEECHAM GROUP PLC (GB) 1988-07-06 — — EP disclosed
Send feedback